Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis - Wikidata - wikimedia - TriplyDB

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis

http://www.wikidata.org/entity/Q35177819

about

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritis Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis.Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis.Insights from populations at risk for the future development of classified rheumatoid arthritis Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.Anti-collagen type II antibodies in patients with very early synovitis.Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis pati Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis.Serologic testing in connective tissue diseases Treating very early rheumatoid arthritis Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis.Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis Rheumatoid Arthritis: Early diagnosis and treatment outcomes.The impact of inflammation on metabolomic profiles in patients with arthritis.Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis.Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.Autoantibodies to posttranslational modifications in rheumatoid arthritis.Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia.

P2860

Q24675281-1CDC930E-757F-45A4-9254-E2C6B04A33BA Q26991453-F02AE91F-02B1-4D07-86F3-B9ACB8BBB7AB Q28590712-AFD0D20F-FA78-4C54-A37B-596A5C471E6E Q33665938-00018464-9254-4CE3-9FE1-1EA84922AD64 Q33669345-123BC12A-63F1-4B4C-A4AB-D175234112E9 Q34551260-C7A55A11-826C-4DD3-810C-5C49350C7B5D Q34604615-DCABC260-C688-4C13-A22E-65213D6E4760 Q34700316-4E4330A4-5390-4ACA-A679-C88A3D58E01C Q35058065-6ED1AE33-E812-4F59-A407-303453378672 Q35094171-ECAE660B-9EAA-49DD-A072-CE29C22A1E06 Q35096891-A2B4C1FC-6E50-49C0-A787-6691AA570FC4 Q35193733-571594EE-286C-4530-80DF-43EAFF19A929 Q35555021-1BAA86AC-9CA3-4FF4-8CFD-D3F064BB7420 Q35605590-8EC778BF-FB40-428F-AB6D-877E2CEEE04D Q35617658-ED281EDB-6747-49ED-9D11-E6F78CB0A80F Q35636615-F30DC9F7-E98F-4D12-8AE1-8B3AA5008016 Q35741161-2EE6CEEC-4C53-4D46-A331-339A7498113A Q35760039-75FEAF57-2573-470E-A15C-A002D4020CB9 Q35840775-945245C5-55B2-43D0-9C23-60BB1C2D1E8A Q35953226-558ED1B7-0E29-405D-A8A7-8C3CA4820BD2 Q36256317-9FF97C2A-6F56-4B5A-BE13-3D6B4CB83C05 Q36596130-2A37CB4D-3634-4E94-8720-8B5D54A10881 Q36761906-419A2540-77EB-4E69-85E6-95306258EA5F Q36968767-390A0403-9EE1-42EC-A7F3-E866CB0AE0A2 Q37155766-640DC24D-FEBF-4ABB-87A3-5CEFEF4551DD Q37343272-CD1B2838-4D7C-4D37-9DA1-41053038EA73 Q37587406-AECD6747-43A7-47DE-A877-7701375E89AC Q37624583-728810C5-5BAE-4117-A71E-B15BB258D2B2 Q37693939-C76AC968-9279-4035-A17F-5B4F4C69916E Q38944886-9D1E3788-2B0E-44BB-8B6B-3451ACE57D30

P2860

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis

http://www.wikidata.org/entity/Q35177819

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Predictive value of antibodies ...... y early inflammatory arthritis

@ast

Predictive value of antibodies ...... y early inflammatory arthritis

@en

type

label

Predictive value of antibodies ...... y early inflammatory arthritis

@ast

Predictive value of antibodies ...... y early inflammatory arthritis

@en

prefLabel

Predictive value of antibodies ...... y early inflammatory arthritis

@ast

Predictive value of antibodies ...... y early inflammatory arthritis

@en

P1433

Q35177819-FB2A8186-77D4-426A-89AA-25D849E11306

P1476

Q35177819-30642E36-491E-45A7-92DB-8192F765349D

P2093

Q35177819-12F9F6AC-C6C7-4F3C-A87A-AB57D7AAA3F3

Q35177819-1D01E0A5-2BFD-4C0E-AD17-4638BA53B3AD

Q35177819-2D9E7C2C-C4CA-48C0-AC92-0781FBEC3B9D

Q35177819-44365219-9611-4CE5-907D-4CD546B98819

Q35177819-62CDA9F0-E644-41FA-94C3-E0E9E3F4FD70

Q35177819-C152A05C-BF78-45A2-B6DA-B8C2C3A2E869

Q35177819-E019B2EC-FFCF-4EEE-9B9B-DEF054429CC4

Q35177819-E3EC6D5C-2CDF-4D77-BA46-DEBD965B40A6

Q35177819-E854B8E5-FEB2-413C-8AD3-C689508217B3

Q35177819-FE95E901-3973-4212-9640-BCA229236064

P2860

Q35177819-18ABED9C-C720-4334-AFE1-66437E907CA2

Q35177819-196FC1E4-1FED-431A-BF36-5D65E2CEA4BC

Q35177819-1D383993-9696-4313-8DDD-DE0846C301EE

Q35177819-2BEA997C-014E-484A-A584-32A5C91B10C8

Q35177819-37A37DE4-C8F2-46C1-9D68-536084145503

Q35177819-499D2F9F-761C-4B97-A52E-5E32C7E0C194

Q35177819-5092D8C0-456E-41A9-BA0C-7D6A387219B3

Q35177819-55935081-7DFA-409A-8D85-CA200BFE8CE9

Q35177819-56837737-82B1-48B1-BAFC-0C22CC0180D8

Q35177819-6D571F20-8171-4F66-8E09-6E062A443987

P304

Q35177819-E311BB06-0B87-469C-A203-5C0A7E3F157F

P31

Q35177819-C2546EE3-ECEE-451E-B02C-8D8C8ED26CA1

P407

Q35177819-0A222D87-8552-4E2B-9CCD-841F7A85E410

P433

Q35177819-B084B08F-514A-4BD7-AB9A-33A8D4CE5795

P478

Q35177819-2DE4DACB-B034-48E4-8DBF-615CB4640008

P50

Q35177819-F9BB3DF7-5E75-49C6-A473-3F18CBC5CA33

P577

Q35177819-15B119C1-EB6D-4D03-BBE5-377B0F76104A

P698

Q35177819-2861B2C8-03D1-47D0-A20C-5E5FB6054D68

P921

Q35177819-ECA89319-3B25-4E8E-BD4B-F4946437BA15

P932

Q35177819-0449A59C-3822-4E68-BD8D-3EDCD8050135

P1433

The Journal of Rheumatology

P1476

Predictive value of antibodies ...... y early inflammatory arthritis

@en

P2093

Caroline Gordon

http://www.w3.org/2001/XMLSchema#string

Christopher D Buckley

http://www.w3.org/2001/XMLSchema#string

David M Carruthers

http://www.w3.org/2001/XMLSchema#string

Deva Situnayake

http://www.w3.org/2001/XMLSchema#string

George D Kitas

http://www.w3.org/2001/XMLSchema#string

Karim Raza

http://www.w3.org/2001/XMLSchema#string

Mike Breese

http://www.w3.org/2001/XMLSchema#string

Mike Salmon

http://www.w3.org/2001/XMLSchema#string

Peter Nightingale

http://www.w3.org/2001/XMLSchema#string

Tanya Potter

http://www.w3.org/2001/XMLSchema#string

P2860

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Early rheumatoid arthritis: time to aim for remission?

Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

Clinical utility of the anti-CCP assay in patients with rheumatic diseases.

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

P304

231-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15693082

http://www.w3.org/2001/XMLSchema#string

P921

P932

3160476

http://www.w3.org/2001/XMLSchema#string